Towards a framework for evaluating and grading evidence in public health

Health Policy

Volumn 119, Issue 6, 2015, Pages 732-736

  Harder, Thomas ^a   Abu Sin, Muna ^a   Bosch Capblanch, Xavier ^b   Bruno Coignard, ^c   de Carvalho Gomes, Helena ^d   Duclos, Phillippe ^e   Eckmanns, Tim ^a   Elder, Randy ^f   Ellis, Simon ^h   Forland, Frode ^g   Garner, Paul ⁱ   James, Roberta ^j   Jansen, Andreas ^d   Krause, Gérard ^k   Lévy Bruhl, Daniel ^c   Morgan, Antony ^g   Meerpohl, Joerg J ^l   Norris, Susan ^e   Rehfuess, Eva ^m   Sánchez Vivar, Alex ⁿ   Schünemann, Holger ^o   Takla, Anja ^a   Wichmann, Ole ^a   Zingg, Walter ^p   Zuiderent Jerak, Teun ^q   more..

^a ROBERT KOCH INSTITUTE   (Germany)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c INSTITUT DE VEILLE SANITAIRE   (France)

^d EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

^h NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

ⁱ LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^j Scottish Intercollegiate Guidelines Network (SIGN)   (United Kingdom)

^k HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^l German Cochrane Center   (Germany)

^m UNIVERSITY OF MUNICH   (Germany)

ⁿ HEALTH PROTECTION SCOTLAND   (United Kingdom)

^o MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^p GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^q LINKÖPING UNIVERSITY   (Sweden)

more..

Author keywords

Evidence based health care; GRADE; Infectious diseases; PRECEPT; Public health

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CONCEPTUAL FRAMEWORK; DECISION MAKING; DISEASE SURVEILLANCE; GERMANY; HEALTH CENTER; HUMAN; INFECTION; INFECTION CONTROL; INFECTION PREVENTION; PEER REVIEW; PUBLIC HEALTH; RISK FACTOR; ROTAVIRUS INFECTION; SYSTEMATIC REVIEW (TOPIC); VACCINATION; WORLD HEALTH ORGANIZATION; COMMUNICABLE DISEASE CONTROL; COOPERATION; DISEASE OUTBREAKS; EVIDENCE BASED PRACTICE; ORGANIZATION; PROCEDURES;

COMMUNICABLE DISEASE CONTROL; CONGRESSES AS TOPIC; COOPERATIVE BEHAVIOR; DISEASE OUTBREAKS; EVIDENCE-BASED PRACTICE; HUMANS; PUBLIC HEALTH;

EID: 84930085424     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2015.02.010     Document Type: Article

References (16)

1. Evidence-based methodologies for public health How to assess the best available evidence when time is limited and there is a lack of sound evidence 2011, European Centre for Disease Prevention and Control (ECDC), Stockholm.
2. Balshem H., Helfand M., Schunemann H.J., Oxman A.D., Kunz R., Brozek J., Vist G.E., Falck-Ytter Y., Meerpohl J., Norris S., Guyatt G.H. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011, 64:401-406.
3. Harder T., Takla A., Rehfuess E., Sanchez-Vivar A., Matysiak-Klose D., Eckmanns T., Krause G., de Carvalho Gomes H., Jansen A., Ellis S., Forland F., James R., Meerpohl J.J., Morgan A., Schunemann H., Zuiderent-Jerak T., Wichmann O. Evidence-based decision-making in infectious diseases epidemiology, prevention and control: matching research questions to study designs and quality appraisal tools. BMC Medical Research Methodology 2014, 14:69.
4. Spencer F.A., Iorio A., You J., Murad M.H., Schunemann H.J., Vandvik P.O., Crowther M.A., Pottie K., Lang E.S., Meerpohl J.J., Falck-Ytter Y., Alonso-Coello P., Guyatt G.H. Uncertainties in baseline risk estimates and confidence in treatment effects. British Medical Journal 2012, 345:e7401.
5. Schunemann H.J., Oxman A.D., Brozek J., Glasziou P., Jaeschke R., Vist G.E., Williams J.W., Kunz R., Craig J., Montori V.M., Bossuyt P., Guyatt G.H., Group G.W. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. British Medical Journal 2008, 336:1106-1110.
6. Duclos P., Durrheim D.N., Reingold A.L., Bhutta Z.A., Vannice K., Rees H. Developing evidence-based immunization recommendations and GRADE. Vaccine 2012, 31:12-19.
7. WHO SAGE Guidance for the development of evidence-based vaccine-related recommendations 2014, WHO SAGE, Geneva.
8. Bohren M.A., Hunter E.C., Munthe-Kaas H.M., Souza J.P., Vogel J.P., Gulmezoglu A.M. Facilitators and barriers to facility-based delivery in low- and middle-income countries: a qualitative evidence synthesis. Reproductive Health 2014, 11:71.
9. Kredo T., Ford N., Adeniyi F.B., Garner P. Decentralising HIV treatment in lower- and middle-income countries. The Cochrane Database of Systematic Reviews 2013, 6. CD009987.
10. Koch J., Wiese-Posselt M., Remschmidt C., Wichmann O., Bertelsmann H., Garbe E., Hengel H., Meerpohl J.J., Mas Marques A., Oppermann H. Background paper to the recommendation for routine rotavirus vaccination of infants in Germany. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2013, 56:957-984.
11. Lopes M.H., Sartori A.M., Mascheretti M., Chaves T.S., Andreoli R.M., Basso M., Barone A.A. Intervention to increase influenza vaccination rates among healthcare workers in a tertiary teaching hospital in Brazil. Infection Control and Hospital Epidemiology: The Official Journal of the Society of Hospital Epidemiologists of America 2008, 29:285-286.
12. Sartor C., Tissot-Dupont H., Zandotti C., Martin F., Roques P., Drancourt M. Use of a mobile cart influenza program for vaccination of hospital employees. Infection Control and Hospital Epidemiology: The Official Journal of the Society of Hospital Epidemiologists of America 2004, 25:918-922.
13. Campbell C.A., Hahn R.A., Elder R., Brewer R., Chattopadhyay S., Fielding J., Naimi T.S., Toomey T., Lawrence B., Middleton J.C., Task Force on Community Preventive S. The effectiveness of limiting alcohol outlet density as a means of reducing excessive alcohol consumption and alcohol-related harms. American Journal of Preventive Medicine 2009, 37:556-569.
14. Joffe M., Mindell J. Complex causal process diagrams for analyzing the health impacts of policy interventions. American Journal of Public Health 2006, 96:473-479.
15. Guyatt G.H., Oxman A.D., Kunz R., Woodcock J., Brozek J., Helfand M., Alonso-Coello P., Glasziou P., Jaeschke R., Akl E.A., Norris S., Vist G., Dahm P., Shukla V.K., Higgins J., Falck-Ytter Y., Schunemann H.J., Group G.W. GRADE guidelines: 7. Rating the quality of evidence-inconsistency. Journal of Clinical Epidemiology 2011, 64:1294-1302.
16. Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) 2011, European Centre for Disease Prevention and Control (ECDC), Stockholm.